
Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Stock Performance (90 Days)
Layoff History
Recent News
Other Drug Manufacturers - Specialty & Generic Companies
View All →Frequently Asked Questions
Has Greater Cannabis Company, Inc. had layoffs?
How many employees does Greater Cannabis Company, Inc. have?
What industry is Greater Cannabis Company, Inc. in?
Is Greater Cannabis Company, Inc. a publicly traded company?
Where is Greater Cannabis Company, Inc. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.